Schedule 13D ownership disclosure

AdvanSource Biomaterials Corp

Security class unavailable · CUSIP: 00767T109

Event date: 2021-10-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
25,570,490
Percent of class
51.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-025673
Form type
SC 13D
Filer
Nordicus Partners Corp
CIK
CIK 1011060
Filed
Oct 18, 2021
Reporting period
Oct 12, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub